Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

ClinicalTrials.gov ID: NCT05609578

Public ClinicalTrials.gov record NCT05609578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 1:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Trial of Combination Therapies With Adagrasib in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study CA239-0010 is an open-label, Phase 2 clinical trial evaluating the clinical efficacy of adagrasib in combination with pembrolizumab and chemotherapy in the first-line setting for patients with advanced NSCLC with TPS ≥ 1%, TPS \<50% and KRAS G12C mutation

Study identification

NCT ID
NCT05609578
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mirati Therapeutics Inc.
Industry
Enrollment
90 participants

Conditions and interventions

Interventions

Drug · Combination Product

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 22, 2022 (Actual)
Primary completion
Sep 30, 2026 (Estimated)
Completion
Dec 1, 2026 (Estimated)
Last update posted
Jun 23, 2026

2022 – 2026

United States locations

U.S. sites
59
U.S. states
14
U.S. cities
48
Facility City State ZIP Site status
Local Institution - 017-936C Fountain Valley California 92708 —
Local Institution - 017-936 Fountain Valley California 92708 —
Local Institution - 017-851 Fullerton California 92835 —
Local Institution - 017-540 San Francisco California 94158 —
Local Institution - 017-872-I Aurora Colorado 80012 —
Local Institution - 017-872-G Boulder Colorado 80303 —
Local Institution - 017-872-D Colorado Springs Colorado 80907 —
Local Institution - 017-872-J Colorado Springs Colorado 80920 —
Local Institution - 017-872-B Denver Colorado 80218 —
Local Institution - 017-872-F Denver Colorado 80220 —
Local Institution - 017-872-A Lakewood Colorado 80228 —
Local Institution - 017-872-C Littleton Colorado 80218 —
Local Institution - 017-872 Lone Tree Colorado 80124 —
Local Institution - 017-872-E Pueblo Colorado 81003 —
Local Institution - 017-872-H Thornton Colorado 80260 —
Local Institution - 017-829 Jacksonville Florida 32224 —
Local Institution - 017-898 Lakeland Florida 33812 —
Local Institution - 017-972 Chicago Illinois 60637 —
Local Institution - 017-820J Fairway Kansas 66205 —
Local Institution - 017-820A Kansas City Kansas 66160 —
Local Institution - 017-820B Kansas City Kansas 66160 —
Local Institution - 017-820C Kansas City Kansas 66160 —
Local Institution - 017-820H Kansas City Kansas 66160 —
Local Institution - 017-820I Overland Park Kansas 66210 —
Local Institution - 017-820 Westwood Kansas 66205 —
Local Institution - 017-388 Boston Massachusetts 02215 —
Local Institution - 017-808 Boston Massachusetts 02215 —
Local Institution - 017-811 Novi Michigan 48377 —
Local Institution - 017-838B Minneapolis Minnesota 55404 —
Local Institution - 017-838C Minneapolis Minnesota 55404 —
Local Institution - 017-830 Rochester Minnesota 55905 —
Local Institution - 017-838 Saint Louis Park Minnesota 55416 —
Local Institution - 017-838A Saint Louis Park Minnesota 55426-5000 —
Local Institution - 017-820F Kansas City Missouri 64116 —
Local Institution - 017-820E Kansas City Missouri 64154 —
Local Institution - 017-820D Lee's Summit Missouri 64064 —
Local Institution - 017-820G North Kansas City Missouri 64116 —
Local Institution - 017-080 Babylon New York 11702 —
Local Institution - 017-088 Brooklyn New York 11210 —
Local Institution - 017-587 East Syracuse New York 13057 —
Local Institution - 017-087 New Hyde Park New York 11042 —
Local Institution - 017-085 New York New York 10028 —
Local Institution - 017-082 Patchogue New York 11772 —
Local Institution - 017-086 Port Jefferson New York 11776 —
Local Institution - 017-081 Port Jefferson Station New York 11776 —
Local Institution - 017-535 Port Jefferson Station New York 11776 —
Local Institution - 017-084 Riverhead New York 11901 —
Local Institution - 017-083 The Bronx New York 10469 —
Local Institution - 017-818 Cleveland Ohio 44195 —
Local Institution - 017-879 Dallas Texas 75246 —
Local Institution - 017-878 Longview Texas 75601 —
Local Institution - 017-878-B Palestine Texas 75801 —
Local Institution - 017-878-C Paris Texas 75460 —
Local Institution - 017-878-A Tyler Texas 75702 —
Local Institution - 017-814-A Arlington Virginia 22205 —
Local Institution - 017-814 Fairfax Virginia 22031 —
Local Institution - 017-814-B Gainesville Virginia 20155 —
Local Institution - 017-814-C Reston Virginia 20190 —
Local Institution - 017-909 Bellingham Washington 98225 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05609578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2026 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05609578 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →